Loading…
Lobbying Income
$6.1M
Filings
165
Unique Clients
5
Active Period
1999–2016
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
First Responder Anthrax Preparedness Act
2016 · first_quarter · Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
Client expense: — · Firm income: $31,000
Matched citations: HR1300
Strengthening Public Health Emergency Response Act of 2016
2016 · first_quarter · Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
Client expense: — · Firm income: $31,000
Matched citations: HR 3299
First Responder Anthrax Preparedness Act
2016 · first_quarter · Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
Client expense: — · Firm income: $31,000
Matched citations: S.1915
First Responder Anthrax Preparedness Act
2015 · fourth_quarter · Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
Client expense: — · Firm income: $46,000
Matched citations: HR1300
Strengthening Public Health Emergency Response Act of 2016
2015 · fourth_quarter · Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
Client expense: — · Firm income: $46,000
Matched citations: HR 3299
First Responder Anthrax Preparedness Act
2015 · fourth_quarter · Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
Client expense: — · Firm income: $46,000
Matched citations: S.1915
Department of Veterans Affairs Claims Backlog Reduction Act of 2002
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: H.R. 5533
To extend the program under which temporary extended unemployment compensation is provided, and for other purposes.
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: H.R. 5587
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: H.R. 5647
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
2006 · year_end · Client: SANOFI PASTEUR
NIAID and HHS OPHEMCE vaccine research and acquistion programs and appropriations; pandemic influenza research and preparedenss; CDC vaccine research and related appropriations; vaccine safety; H.R 5647, S. 3708, H.R. 2863, H.R. 4939
Client expense: — · Firm income: $100,000
Matched citations: H.R 5647
A bill to amend the Internal Revenue Code of 1986 to add meningococcal vaccines to the list of taxable vaccines for purposes of the Vaccine Injury Compensation Trust Fund.
2006 · year_end · Client: SANOFI PASTEUR
Vaccine excise tax covering newly recommended vaccines under the Vaccine Injury Compensation Program; S. 1008, H.R. 5970
Client expense: — · Firm income: $100,000
Matched citations: S. 1008
Bioterror and Pandemic Preparedness Protection Act
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 1437
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 1527
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 1821
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 1826
National Biodefense and Pandemic Preparedness Act of 2005
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 1880
Affordability in the Individual Market Act
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S.2554
Federal Workforce Performance Appraisal and Management Improvement Act of 2006
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 3492
Mercury Market Minimization Act of 2006
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 3627
Pandemic and All-Hazards Preparedness Act
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 3678
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 3708
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
2006 · year_end · Client: SANOFI PASTEUR
NIAID and HHS OPHEMCE vaccine research and acquistion programs and appropriations; pandemic influenza research and preparedenss; CDC vaccine research and related appropriations; vaccine safety; H.R 5647, S. 3708, H.R. 2863, H.R. 4939
Client expense: — · Firm income: $100,000
Matched citations: S. 3708
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 843
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 96
Attacking Viral Influenza Across Nations Act of 2005
2006 · year_end · Client: SANOFI PASTEUR
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: — · Firm income: $100,000
Matched citations: S. 969
Source: Senate LDA